In this respect, we postulated that compensatory L-cell secretion of GLP-1 has occurred in our T2D population who were generally still in the early stages of their diabetes (34)
As prescriptions for drugs like semaglutide and tirzepatide surge, attention is shifting from drug availability to a critical enabler the medical devices required to deliver these therapies safely, sustainably, and at scale. He mentions that prefilled and reusable injection pens have emerged as the preferred delivery method, offering precision, convenience, and improved patient adherence
Mark the date you first pierce each vial
More severe side effects may include pancreatitis and gallbladder issues, though these are less common
Tirzepatide, the dual GIP/GLP-1 agonist, has shown even greater efficacy in the SURMOUNT trials, with patients losing up to 22.5% of body weight
That said, some patients report subjective increases in urination after starting therapy